Rate My Professor Alison Rodger

Rodger’s research interests center on infectious diseases epidemiology, with a focus on HIV prevention, transmission risk assessment, treatment as prevention, pre-exposure prophylaxis, HIV self-testing, and management of viral hepatitis B and C among high-risk populations such as gay, bisexual, and other men who have sex with men. She led the PARTNER1 and PARTNER2 studies, key publications in The Lancet (2016 and 2019), which demonstrated zero HIV transmissions from virally suppressed individuals to serodifferent partners during over 77,000 episodes of condomless anal intercourse, providing pivotal evidence for the global 'Undetectable = Untransmittable' (U=U) public health message. Other significant works include 'HCV reinfection incidence and spontaneous clearance in HIV-positive men who have sex with men following treatment with direct-acting antivirals' (Journal of Hepatology, 2017), 'Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment' (The Lancet HIV, 2014), and studies on mpox stigma and sexual health needs in inclusion health populations. She serves on steering committees for NIHR-funded Health Protection Research Units and contributes to projects on biosecurity, STI risk reduction, and blood-borne virus care cascades. Her epidemiological research has influenced UK HIV testing strategies and international prevention guidelines.